Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

2341 - 2350 of 3841 results found

Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas: Guideline From the College of American Pathologists in Collaboration With the American Association of Neuropathologists, Association for Molecular Pathology, and Society for Neuro-Oncology

MeSH Terms

In Situ Hybridization; Fluorescence (E05.393.285.350); Comparative Genomic Hybridization (E05.393.285.240); Molecular Probe Techniques (E05.601); Brain Neoplasms (C04.588.614.250.195); Diagnosis (E01); Genetic Testing (E05.200.562); Histological Techniques (E05.200.750); Histocytological Preparation Techniques (E05.200.750.600); Immunohistochemistry (E05.200.750.551.512); Molecular Diagnostic Techniques (E05.200.880); Biopsy (E05.200.998.054); Genetic Techniques (E05.393)

Guideline Contact
Nicole Thomas ([email protected])
Keywords
Diffuse gliomas, dg, molecular testing
Publication Date
17-Feb-22
Publication Scope
assessment
prognosis
Guideline Publication Status
Published
Languages
English
Authors
CAP (US)
Publication Year
2022

Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology

MeSH Terms
Neoplasms (C04); Biomarkers; Pharmacological (D23.101.137); Colorectal Neoplasms (C04.588.274.476.411.307)
Guideline Contact
[email protected]
Publication Date
06-Feb-17
Expected Publication Date
In Review
Publication Scope
assessment
Countries of Application
United States
Guideline Publication Status
Under Review
Languages
English
Authors
ASCO (US)
CAP (US)
Publication Year
2017

Molecular Biomarkers for the Evaluation of Colorectal Carcinoma: Guideline From the ASCP, CAP, AMP, and ASCO

MeSH Terms

Intestinal Neoplasms (C06.405.249.411); Gastrointestinal Neoplasms (C06.405.249); Histological Techniques (E01.370.225.750); Histocytochemistry (E01.370.225.750.551); Histocytological Preparation Techniques (E01.370.225.750.600); Neoplasms (C04); Neoplasms by Histologic Type (C04.557); Carcinoma (C04.557.470.200); Neoplasms; Glandular and Epithelial (C04.557.470); Digestive System Neoplasms (C04.588.274); Colorectal Neoplasms (C04.588.274.476.411.307); Immunohistochemistry (E05.200.500.607.512); Individualized Medicine (E02.574); Molecular Diagnostic Techniques (E01.370.225.880); Diagnosis (E01)

Guideline Contact
Christina Ventura ([email protected])
Keywords
colorectal cancer, crc, biomarker testing, molecular marker testing
Publication Date
06-Feb-17
Expected Publication Date
Update: Q4, 2025
Publication Scope
assessment
Countries of Application
United States
Guideline Publication Status
Development
Languages
English
Authors
CAP (US)
Publication Year
2017

Molecular Testing for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the CAP/IASLC/AMP Guideline

MeSH Terms
Neoplasms (C04); Lung Neoplasms (C04.588.894.797.520)
Guideline Contact
[email protected]
Publication Date
05-Feb-18
Publication Scope
assessment
screening
Countries of Application
United States
Guideline Publication Status
Published
Languages
English
Authors
ASCO (US)
Publication Year
2018

Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology

MeSH Terms

CADASIL / diagnosis

CADASIL / genetics

CADASIL / therapy

Cerebral Small Vessel Diseases* / diagnosis

Cerebral Small Vessel Diseases* / genetics

Cerebral Small Vessel Diseases* / therapy

Consensus

High-Temperature Requirement A Serine Peptidase 1

Humans

Leukoencephalopathies

Neurology

Guideline Contact
M. Mancuso, Department of Clinical and Experimental Medicine, Neurological Institute, Building 13, Santa Chiara Hospital, Via Roma 67, 56100 Pisa, Italy (tel.: +39 50 992560; fax: +39 50 992748; e-mail: [email protected]).
Keywords
Fabry; cathepsin-A-related arteriopathy with strokes and leukoencephalopathy (CARASAL); cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL); cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL); cerebral small-vessel disease; lactic acidosis and stroke-like episodes (MELAS); mitochondrial encephalopathy; monogenic cerebral small-vessel disease; pontine autosomal dominant microangiopathy and leukoencephalopathy (PADMAL); retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S); type IV collagen (COL4)A1/2.
Publication Date
20 March 2020
Date of Last Evidence Search
November 2018
Methods Applied
Delphi methodology
Publication Scope
Diagnosis
Evidence-Based Medicine
Management: Treatment
Treatment
Assessment, diagnosis, investigation
Diagnosis
Diagnosis, Treatment
Countries of Application
Europe
Guideline Publication Status
Published
Languages
English
Authors
14
Willingness to Collaborate
Yes